GAMMA Investing »

Aurinia Pharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 2.8k 5.01
2023-12-31 $5.9k 778 7.54

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals